{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:06:39Z","timestamp":1774620399678,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Blood culture contamination is a significant problem that can lead to misdiagnosis, unnecessary antibiotic use, and increased workload. This study aimed to determine the blood culture contamination rates in a tertiary hospital and to evaluate the factors associated with contamination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective descriptive study included blood culture samples collected at a tertiary hospital between January 2023 and December 2023. Cultures from patients aged\u2009\u2265\u200918 years were evaluated. Growth of coagulase-negative staphylococci (CoNS) and other skin flora agents that were not considered clinically significant were classified as contamination. Contamination risk factors, including the sampling unit, sampling period, and healthcare personnel who collected the cultures, were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 7716 blood cultures from 2388 patients were included. 11.8% of the cultures were defined as contaminated. Contamination rates were found to be significantly higher in internal medicine wards (12.5%) and intensive care units (13.5%) compared to surgical wards (3.6%) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In logistic regression analysis, the risk of contamination was found to be 3 times higher in blood cultures taken from internal medicine wards and 4.1 times higher in ICUs compared to surgical wards (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). Blood cultures obtained by intern doctors (sixth-year medical students) were independently associated with contamination (OR\u2009=\u20091.68;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The risk of contamination was higher in blood cultures taken between July and December (OR\u2009=\u20091.23;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Blood culture contamination is a multifactorial problem influenced by factors such as the sampling unit and staff experience. These findings highlight the need for targeted quality improvement interventions, particularly structured training for newly rotating clinical staff.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12945-z","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T15:45:34Z","timestamp":1771688734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for blood culture contamination in a tertiary hospital: a one-year retrospective analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Tuba","family":"\u0130lgar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aybeg\u00fcm","family":"\u00d6z\u015fahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"issue":"4","key":"12945_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1128\/CMR.00062-05","volume":"19","author":"KK Hall","year":"2006","unstructured":"Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev. 2006;19(4):788\u2013802.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"12945_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/ice.2021.111","volume":"43","author":"JM Klucher","year":"2022","unstructured":"Klucher JM, Davis K, Lakkad M, Painter JT, Dare RK. Risk factors and clinical outcomes associated with blood culture contamination. Infect Control Hosp Epidemiol. 2022;43(3):291\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"12945_CR3","doi-asserted-by":"crossref","unstructured":"Schinkel M, Boerman A, Carroll K, Cosgrove SE, Hsu YJ, Klein E, et al. Impact of blood culture contamination on antibiotic use, resource utilization, and clinical outcomes: a retrospective cohort study in Dutch and US hospitals. Open Forum Infect Dis. 2024;11(2).","DOI":"10.1093\/ofid\/ofad644"},{"key":"12945_CR4","doi-asserted-by":"crossref","unstructured":"Doern GV, Carroll KC, Diekema DJ, Garey KW, Rupp ME, Weinstein MP, et al. Practical guidance for clinical microbiology laboratories: a comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the problem. Clin Microbiol Rev. 2019;33(1).","DOI":"10.1128\/CMR.00009-19"},{"issue":"2","key":"12945_CR5","first-page":"307","volume":"46","author":"NA Mokhtar","year":"2024","unstructured":"Mokhtar NA, Ting SY, Abidin NZZ, Hameed AA, Zulaikah M, Mustapa NI, et al. The rate of blood culture contamination and common organisms isolated in Malaysian public hospitals. Malays J Pathol. 2024;46(2):307\u201314.","journal-title":"Malays J Pathol"},{"key":"12945_CR6","doi-asserted-by":"crossref","unstructured":"Sautter RL, Parrott JS, Nachamkin I, Diel C, Tom RJ, Bobenchik AM, et al. American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis. Clin Microbiol Rev. 2024;37(4).","DOI":"10.1128\/cmr.00087-24"},{"key":"12945_CR7","doi-asserted-by":"crossref","unstructured":"Sacchetti B, Travis J, Steed LL, Webb G. Identification of the main contributors to blood culture contamination at a tertiary care academic medical center. Infect Prev Pract. 2022;4(3).","DOI":"10.1016\/j.infpip.2022.100219"},{"issue":"8","key":"12945_CR8","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ajic.2018.12.020","volume":"47","author":"C Dempsey","year":"2019","unstructured":"Dempsey C, Skoglund E, Muldrew KL, Garey KW. Economic health care costs of blood culture contamination: a systematic review. Am J Infect Control. 2019;47(8):963\u20137.","journal-title":"Am J Infect Control"},{"issue":"3","key":"12945_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/0300-1652.132038","volume":"55","author":"IK Chukwuemeka","year":"2014","unstructured":"Chukwuemeka IK, Samuel Y. Quality assurance in blood culture: A retrospective study of blood culture contamination rate in a tertiary hospital in Nigeria. Niger Med J. 2014;55(3):201\u20133.","journal-title":"Niger Med J"},{"issue":"8","key":"12945_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1017\/ice.2020.1335","volume":"42","author":"J LeRose","year":"2021","unstructured":"LeRose J, Sandhu A, Polistico J, Ellsworth J, Cranis M, Jabbo L, et al. The impact of coronavirus disease 2019 (COVID-19) response on central-line\u2013associated bloodstream infections and blood culture contamination rates at a tertiary-care center in the Greater Detroit area. Infect Control Hosp Epidemiol. 2021;42(8):997\u20131000.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"12945_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12879-023-08428-0","volume":"23","author":"BM Aiesh","year":"2023","unstructured":"Aiesh BM, Daraghmeh D, Abu-Shamleh N, Joudallah A, Sabateen A, Al Ramahi R. Blood culture contamination in a tertiary care hospital: a retrospective three-year study. BMC Infect Dis. 2023;23(1):448.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"12945_CR12","first-page":"432","volume":"10","author":"AY Alnami","year":"2015","unstructured":"Alnami AY, Aljasser AA, Almousa RM, Torchyan AA, BinSaeed AA, Al-Hazmi AM, et al. Rate of blood culture contamination in a teaching hospital: A single center study. J Taibah Univ Med Sci. 2015;10(4):432\u20136.","journal-title":"J Taibah Univ Med Sci"},{"key":"12945_CR13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1128\/CMR.00062-05","volume":"19","author":"KK Hall","year":"2006","unstructured":"Hall KK, Lyman JA. Updated Review of Blood Culture Contamination. Clin Microbiol Rev. 2006;19:788\u2013802.","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"12945_CR14","doi-asserted-by":"publisher","first-page":"e0242533","DOI":"10.1371\/journal.pone.0242533","volume":"15","author":"D Yu","year":"2020","unstructured":"Yu D, Ininbergs K, Hedman K, Giske CG, Str\u00e5lin K, \u00d6zenci V. Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID-19. PLoS ONE. 2020;15(11):e0242533.","journal-title":"PLoS ONE"},{"issue":"1","key":"12945_CR15","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1017\/ash.2022.22","volume":"2","author":"S Liaquat","year":"2022","unstructured":"Liaquat S, Baccaglini L, Haynatzki G, Medcalf SJ, Rupp ME. Patient-specific risk factors contributing to blood culture contamination. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e46.","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"2","key":"12945_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/1742-6723.14330","volume":"36","author":"AZ Hills","year":"2024","unstructured":"Hills AZ, Ray M, Williams J, Greenslade J. Benchmarking blood culture quality in the emergency department: contamination, single sets and positivity. Emerg Med Australas. 2024;36(2):206\u201312.","journal-title":"Emerg Med Australas"},{"issue":"5","key":"12945_CR17","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3390\/ijerph19053009","volume":"19","author":"A Tenderenda","year":"2022","unstructured":"Tenderenda A, \u0141ysakowska M, Dargiewicz R, Gawron-Skarbek A. Blood culture contamination: a single general hospital experience of 2-year retrospective study. Int J Environ Res Public Health. 2022;19(5):3009.","journal-title":"Int J Environ Res Public Health"},{"issue":"13\u201314","key":"12945_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.clinbiochem.2012.06.007","volume":"45","author":"SR Snyder","year":"2012","unstructured":"Snyder SR, Favoretto AM, Baetz RA, Derzon JH, Madison BM, Mass D, et al. Effectiveness of practices to reduce blood culture contamination: a laboratory medicine best practices systematic review and meta-analysis. Clin Biochem. 2012;45(13\u201314):999\u20131011.","journal-title":"Clin Biochem"},{"issue":"10","key":"12945_CR19","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.5858\/2005-129-1222-TIBCCA","volume":"129","author":"LG Bekeris","year":"2005","unstructured":"Bekeris LG, Tworek JA, Walsh MK, Valenstein PN. Trends in blood culture contamination: a college of american pathologists Q-tracks study of 356 institutions. Arch Pathol Lab Med. 2005;129(10):1222\u20135.","journal-title":"Arch Pathol Lab Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12945-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12945-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12945-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:01:18Z","timestamp":1774616478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12945-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12945"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12945-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The study was approved by the Recep Tayyip Erdo\u011fan University non-interventional clinical research ethics committee, with decision number 2024\/308 dated 19 December 2024. Due to the retrospective nature of the study and the use of anonymized, routinely collected data, the requirement for informed consent was waived by the Recep Tayyip Erdo\u011fan University non-interventional clinical research ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AI-based language tools (ChatGPT, OpenAI) were used solely to improve the fluency and intelligibility of the text.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of artificial intelligence tools"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"653"}}